切片检查钳市场按产品类型、应用、最终用户和分销管道划分 - 全球预测 2025-2032

预计到 2032 年，切片检查钳市场规模将达到 3.4778 亿美元，复合年增长率为 5.77%。

本文对切片检查钳进行了简明扼要的临床和操作概述，反映了影响其应用的手术需求、不断发展的器械设计以及消毒优先事项之间的相互作用。

切片检查钳是诊断性内视镜检查中的基本工具，可用于肺部、胃肠道、妇科和泌尿系统手术中的组织取样。近年来，临床趋势已将切片检查器械推向精密辅助器具的前沿，显着提高了诊断准确性，缩短了手术时间，并影响了后续的治疗决策。随着临床医生优先考虑微创治疗方法，对兼具易用性、触觉回馈和检体品质一致性的器械的需求日益增长。这一趋势正在影响产品研发週期、监管机构的关注点以及医院的采购标准。

技术改进正沿着多个方向发展：材料科学着重于耐腐蚀性和尖端锋利度，符合人体工学的手柄设计旨在减轻临床医生的疲劳，製造公差则确保在狭窄的解剖通道内实现可重复的咬合大小。同时，感染预防措施和消毒流程正在推动可重复使用产品与一次性产品的不同应用模式。这些操作和临床因素与不断变化的筹资策略相互交织，价值评估除了单位成本外，还越来越重视总拥有成本、再处理物流和风险缓解。因此，切片检查钳策略的投资决策必须综合考虑临床效用、生命週期经济性和供应可靠性，并将其纳入采购和产品开发决策中。

不断发展的临床实践、消毒的需求以及製造技术的创新正在从根本上改变切片检查钳的研发和采购。

切片检查钳市场正经历着一场变革性的转变，其根源在于临床实践的改变、供应链的调整以及产品创新。其中一个显着的变化是，在某些临床环境中，为了降低交叉感染风险并简化再处理流程，一次性器械的使用日益普及。这项转变促使一次性器械的设计不断改进，力求在性能上媲美可重复使用的器械，同时兼顾无菌性和物流的考量。同时，可重复使用的器械也在不断发展，采用更先进的高压釜材料，并相容于化学灭菌方法，从而确保其在效用生命週期经济性和环境效益的场合中继续发挥作用。

随着超音波的广泛应用和胃肠内视镜技术的日益精进，人们对器械的精准度和操控性提出了更高的要求。医疗设备製造商正透过优化器械尖端形状、提高器械桿的柔韧性以及增强与各种内视镜通道的兼容性来应对这些需求。除了纯粹的机械改进之外，数位化製程控制和可追溯性功能在再处理器材中的应用也日益普及，这使得医疗机构能够简化合规流程和库存管理。因此，一个能够奖励那些提供临床性能、高效灭菌流程和可靠供应解决方案的製造商的市场正在形成，而支付方和采购部门也越来越多地从更广泛的营运观点来评估产品价值。

检验2025年关税改革对切片检查钳相关人员的筹资策略、采购实务和製造地决策的影响

美国于2025年宣布的关税措施的累积影响，为切片检查钳的采购和全球筹资策略带来了显着的复杂性。关税调整迫使许多製造商和医疗保健采购负责人重新评估其供应商布局，特别是从高关税地区进口的零件和成品。为此，一些原始设备製造商（OEM）正在加快近岸外包和本土化生产，以维持价格稳定、缩短前置作业时间并保护供应链免受贸易政策波动的影响。这些变化不仅仅是交易问题，它们还会影响製造品质系统、监管申报和供应商资格认证的时间表。

采购部门正透过审查合约条款、更加重视总落地成本分析以及签订长期供应协议来应对关税风险。对于经销商和医院采购部门而言，关税带来的成本压力日益增加，促使他们重新重视采购管道多元化和策略性库存管理，以确保业务连续性。此外，关税政策的变化可能促使企业重新评估产品系列，例如整合差异化程度较低的产品、增加SKU复杂性以及降低对进口的依赖。在整个价值链中，合规部门正着重关注产品分类、原产地证明文件以及关税设计方面的优化，力求在不影响安全性和合规性的前提下，合法地优化关税处理流程。最终，这将形成一种更谨慎和注重风险的采购策略，并将贸易政策因素纳入临床供应计划和产品生命週期决策中。

深度細項分析揭示了产品的灭菌途径、操作流程、护理环境和分销网络如何决定其竞争优势。

基于细分市场的洞察揭示了产品属性、临床应用、使用者环境和通路如何相互作用，从而影响切片检查钳市场的策略定位。依产品类型划分，市场可分为可重复使用产品及一次性产品。可重复使用产品可进一步分为高压釜及化学灭菌。一次性产品则进一步分为非无菌和已灭菌。这些区分至关重要，因为灭菌方法、再处理能力和处置程序都会影响其与采购标准和临床工作流程的兼容性。在灭菌能力成熟的高运作医疗机构中，高压釜灭菌的可重复使用器械往往更受欢迎。而对于再处理基础设施有限的医疗机构而言，化学灭菌的可重复使用器械和已灭菌的一次性器械可能更为合适。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 为了提高内视镜诊断的准确性，机器人导航正越来越多地被整合到切片检查钳系统中。
• 正在开发用于柔性轴的先进生物相容性形状记忆合金，以提高其在复杂解剖结构中的操控性。
• 严格的感染控制通讯协定使得门诊护理机构越来越倾向于使用一次性切片检查钳。
• 在肺部诊断领域，冷冻切片检查技术的出现引起了人们的关注，该技术能够有效地获得更大、更完整的组织样本。
• 为了减少长时间内视镜检查过程中的疲劳，我们专注于符合人体工学的手柄设计和增强的触觉回馈。
• 亚太地区癌症发生率上升和内视镜检查计画数量增加，推动了切片检查钳市场的发展。
• 监管政策的调整加强了可重复使用切片检查钳（切片检查钳）的再处理标准，以最大限度地降低交叉感染风险并确保患者安全。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章切片检查钳市场按产品类型划分

• 可重复使用的
  • 高压釜灭菌
  • 化学灭菌
• 一次使用
  • 非无菌
  • 已灭菌

第九章切片检查钳市场按应用领域划分

• 支气管镜检查
  • 传统的
  • 超音波
• 胃肠内视镜检查
  • 大肠镜检查
  • 食道胃十二指肠镜检查
• 妇科
• 泌尿系统

第十章切片检查钳市场（按最终用户划分）

• 门诊手术中心
• 诊所
• 医院

第十一章切片检查钳市场（按分销管道划分）

• 经销商
• 医院采购
• 线上零售

第十二章 各地区切片检查钳市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章切片检查钳市场：按组别划分

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十四章 各国切片检查钳市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十五章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • Olympus Corporation
  • Boston Scientific Corporation
  • Medtronic plc
  • Cook Medical LLC
  • KARL STORZ SE & Co. KG
  • HOYA Corporation
  • Fujifilm Holdings Corporation
  • CONMED Corporation
  • STERIS plc
  • Ambu A/S

The Biopsy Forceps Market is projected to grow by USD 347.78 million at a CAGR of 5.77% by 2032.

A concise clinical and operational overview of biopsy forceps reflecting the intersection of procedural demands, device design evolution, and sterilization priorities influencing adoption

Biopsy forceps are fundamental instruments within diagnostic endoscopy, enabling tissue sampling across pulmonary, gastrointestinal, gynecological, and urological procedures. Recent clinical trends have elevated the role of biopsy tools as precision accessories that materially influence diagnostic yield, procedure time, and downstream therapeutic decisions. As clinicians prioritize minimally invasive pathways, the demand for instruments that balance maneuverability, tactile feedback, and consistent sample quality has intensified. This dynamic is shaping product development cycles, regulatory attention, and hospital procurement criteria in parallel.

Technological refinement has progressed along multiple vectors: materials science focused on corrosion resistance and tip sharpness; ergonomic handle designs to reduce clinician fatigue; and manufacturing tolerances that ensure reproducible bite size within narrow anatomical corridors. Concurrently, infection prevention imperatives and sterilization workflows are driving divergent adoption patterns between reusable and single-use products. These operational and clinical drivers intersect with shifting procurement strategies, where value assessments increasingly weigh total cost of ownership, reprocessing logistics, and risk mitigation alongside unit price. The investment case for a biopsy forceps strategy therefore requires synthesis of clinical utility, lifecycle economics, and supply reliability to inform purchasing and product development decisions.

How clinical practice evolution, sterilization imperatives, and manufacturing innovation are driving a fundamental reshaping of biopsy forceps development and procurement

The landscape for biopsy forceps is undergoing transformative shifts rooted in clinical practice changes, supply chain adaptation, and product innovation. One prominent change is the move toward single-use instruments in select clinical settings to reduce cross-contamination risk and simplify reprocessing workflows. This shift is accompanied by enhanced single-use designs that approach the performance of reusable alternatives while addressing sterility and logistics concerns. At the same time, reusable instruments continue to evolve with improved autoclavable materials and chemical sterilization compatibility, ensuring they remain viable where lifecycle economics and environmental considerations are prioritized.

Procedural advancements such as increased uptake of endobronchial ultrasound and refined gastrointestinal endoscopic techniques have raised expectations for forceps precision and access. Device makers are responding with optimized tip profiles, enhanced shaft flexibility, and compatibility with a broader array of endoscope channels. Beyond pure mechanical improvements, integration of digital process controls and traceability features for reprocessed instruments is becoming more common, enabling healthcare facilities to better manage compliance and inventory. The result is a market that rewards manufacturers who can deliver clinical performance, streamlined sterilization pathways, and resilient supply solutions, while payers and procurement teams increasingly evaluate product value through a broader operational lens.

An examination of how 2025 tariff reforms have reshaped sourcing strategies, procurement practices, and manufacturing footprint decisions for biopsy forceps stakeholders

The cumulative impact of United States tariff actions announced for 2025 has introduced measurable complexity into biopsy forceps procurement and global sourcing strategies. Tariff adjustments have prompted many manufacturers and health system buyers to re-evaluate supplier footprints, particularly for components and finished devices imported from regions subject to elevated duties. In response, some original equipment manufacturers have accelerated nearshoring and onshoring initiatives to preserve price stability, shorten lead times, and insulate supply lines from trade policy volatility. These shifts are not purely transactional; they carry implications for manufacturing quality systems, regulatory filings, and supplier qualification timelines.

Procurement teams have reacted by revising contract terms, increasing emphasis on total landed cost analysis, and seeking longer-term supply commitments to mitigate future tariff exposures. For distributors and hospital procurement departments, tariff-driven cost pressure has reinforced the importance of diversified supplier panels and strategic stockholding to smooth operational continuity. Additionally, tariff dynamics have stimulated discussions around product portfolio rationalization, where less differentiated items may be consolidated to reduce SKU complexity and import dependencies. Across the value chain, compliance functions have heightened focus on classification, country-of-origin documentation, and tariff engineering opportunities that legally optimize duty treatment without compromising safety or regulatory compliance. The overarching effect is a more deliberate, risk-aware sourcing posture that integrates trade policy considerations into clinical supply planning and product lifecycle decisions.

Deep segmentation analysis revealing how product sterilization pathways, procedural applications, care settings, and distribution networks determine competitive differentiation

Segmentation-driven insight reveals how product characteristics, clinical applications, user settings, and distribution pathways jointly influence strategic positioning within the biopsy forceps arena. Based on Product Type, market is studied across Reusable and Single Use. The Reusable is further studied across Autoclavable and Chemical Sterilization. The Single Use is further studied across Non Sterile and Sterile. These distinctions matter because sterilization modality, reprocessing throughput, and end-of-life handling all feed into purchasing criteria and clinical workflow compatibility. Autoclavable reusable instruments are often favored in high-volume centers with mature sterile processing capacity, whereas chemically sterilized reusables or single-use sterile items may better serve facilities with constrained reprocessing infrastructure.

Based on Application, market is studied across Bronchoscopy, Gastrointestinal Endoscopy, Gynecology, and Urology. The Bronchoscopy is further studied across Conventional and Endobronchial Ultrasound. The Gastrointestinal Endoscopy is further studied across Colonoscopy and Esophagogastroduodenoscopy. Application-specific requirements dictate instrument dimensions, bite geometry, and shaft flexibility. For example, endobronchial ultrasound probes require forceps that maintain performance within narrow working channels while delivering adequate tissue for molecular diagnostics. In gastrointestinal procedures, the need for reliable retrieval during colonoscopy or esophagogastroduodenoscopy drives different design trade-offs between grasp strength and maneuverability.

Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals. Each setting imposes unique operational constraints: ambulatory centers prioritize rapid turnover and simplified reprocessing, clinics may seek cost-effective single-use solutions for lower-volume procedures, and hospitals demand a balance of durability and broad procedural compatibility. Based on Distribution Channel, market is studied across Distributors, Hospital Procurement, and Online Retail. Distribution choice affects lead times, aftermarket support, training offerings, and pricing transparency. The interplay of these segmentation dimensions shapes how manufacturers prioritize R&D investment, channel partnerships, and customer support models to match clinical and operational needs.

A comparative regional perspective clarifying how procurement priorities, regulatory frameworks, and manufacturing capacity shape biopsy forceps adoption across global healthcare markets

Regional dynamics exert strong influence on clinical adoption, procurement behavior, and regulatory pathways for biopsy forceps, with distinct drivers observed in the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, emphasis on patient safety, infection control, and bundled procurement has supported exploration of single-use alternatives in specific procedure types, while large integrated delivery networks demand consistency, supplier reliability, and traceable reprocessing practices. Regulatory oversight tends to be rigorous, and reimbursement structures shape hospital-level adoption decisions and tender outcomes.

In Europe, Middle East & Africa, heterogeneous healthcare systems create a patchwork of adoption rates and procurement preferences. Western European markets often lead in innovation uptake and sustainability conversations, applying lifecycle cost assessments and environmental impact considerations to purchasing decisions. By contrast, other countries in the region may prioritize cost containment and supply chain availability, which can favor robust reusable portfolios. Regulatory harmonization efforts in some jurisdictions influence cross-border sourcing and clinical acceptance.

The Asia-Pacific region is characterized by rapid procedural volume growth, expanding access to endoscopic services, and increasing domestic manufacturing capability. Local production capacity is strengthening, driven by investment in precision manufacturing and competitive positioning for both regional and export markets. Across all regions, clinical education, distributor relationships, and regulatory alignment remain critical to translating product innovation into sustained utilization, and successful market entry strategies must be tailored to each regional ecosystem's procurement norms and clinical priorities.

Insights into competitive strategies showing how product innovation, regulatory readiness, and channel partnerships determine long-term differentiation and customer retention

Competitive dynamics among companies in the biopsy forceps space are defined by differentiated product portfolios, regulatory agility, and channel management. Leading firms are investing in manufacturing scalability, enhanced material sciences, and design refinements that deliver consistent tissue acquisition while meeting sterilization and reprocessing standards. Strategic partnerships with endoscope manufacturers and clinical centers are enabling iterative product improvements guided by real-world procedural feedback. In parallel, some players prioritize single-use platforms to address infection control concerns and simplify logistics for ambulatory environments.

Mergers, acquisitions, and distribution agreements continue to be mechanisms for accelerating market access and closing capability gaps, particularly in regions where local regulatory approvals and established distribution networks are critical. Companies that combine robust regulatory affairs capabilities with localized quality systems can shorten time-to-market for new SKUs. Aftermarket services such as clinician training, reprocessing support, and inventory management are increasingly material to competitive positioning, as buyers reward vendors who reduce operational friction. Manufacturers that focus on demonstrable clinical outcomes, rigorous validation studies, and responsive post-sale support are more likely to secure long-term procurement relationships in an environment where clinical performance and logistical reliability carry significant weight.

Actionable strategic priorities for manufacturers and procurement teams to enhance product performance, supply resilience, and commercial differentiation in clinical settings

Industry leaders should adopt a multi-pronged strategy that aligns product design, supply resilience, and customer-centric services to capture clinical preference and procurement trust. Prioritize development of forceps that deliver consistent tissue quality while minimizing additional workflow burden for sterile processing departments, and ensure that design choices reflect the sterilization modalities most prevalent among target end users. Simultaneously, expand single-use offerings where they provide clear infection prevention or workflow advantages, but maintain reusable options for high-volume centers that benefit from lifecycle economics.

Strengthen supply chain resilience by diversifying suppliers, qualifying alternative manufacturing sites, and considering nearshore production to mitigate tariff and logistics risks. Enhance commercial proposals with transparent total landed cost analyses and evidence packages that link device performance to procedural efficiency or diagnostic yield. Invest in clinician education programs and post-sale support to accelerate adoption and reduce procedural variability. Finally, adopt sustainability practices that address end-of-life handling and packaging optimization, recognizing that environmental considerations increasingly influence purchasing decisions across hospitals and health systems. A disciplined execution of these actions will help organizations balance short-term operational needs with long-term strategic positioning.

A transparent methodological exposition describing stakeholder interviews, secondary validation, and triangulation protocols used to derive strategic insights without quantitative estimations

The research underpinning this analysis combines primary qualitative engagement with stakeholders and rigorous secondary source triangulation to ensure a balanced, evidence-based perspective. Primary inputs included structured interviews with clinicians across pulmonology, gastroenterology, gynecology, and urology, in addition to dialogues with sterile processing managers, procurement professionals, and device engineers. These conversations provided granular insights into procedural needs, reprocessing constraints, and procurement decision criteria. Secondary inputs comprised regulatory filings, device instruction for use documentation, clinical procedure guides, and publicly available supplier announcements, which were used to validate themes emerging from primary research.

Data integrity was sustained through cross-verification across independent sources, coding of qualitative responses to identify recurring patterns, and assessment of regulatory and clinical documentation for consistency. Limitations are acknowledged: the research emphasized qualitative drivers and strategic dynamics rather than providing numerical market estimates; variations in regional clinical practice and procurement policies may generate different local outcomes. Ethical protocols were followed in all primary engagements, with interviewees participating on a non-attributable basis unless explicit permission was granted. The methodology is designed to be transparent and reproducible, offering a defensible foundation for the strategic conclusions and recommendations presented.

A decisive synthesis highlighting the practical imperatives for aligning device performance, sterilization workflows, and procurement strategy to support durable clinical adoption

In conclusion, biopsy forceps remain a pivotal class of instruments at the intersection of diagnostic precision and operational practicality. The balance between reusable and single-use solutions will continue to be negotiated across care settings as clinical priorities, sterilization infrastructure, and procurement frameworks evolve. Technology refinement in materials and ergonomics, coupled with heightened attention to infection prevention and supply resilience, creates opportunities for manufacturers that can deliver validated clinical performance alongside predictable lifecycle economics.

Successful market strategies will be those that integrate clinician-centered design, rigorous regulatory readiness, and supply chain flexibility to adapt to trade policy shifts and regional procurement norms. Providers and procurement teams must weigh clinical benefits against operational impacts and choose solutions that support consistent diagnostic outcomes while minimizing procedural and reprocessing burdens. The imperative is clear: align product development and commercial execution with the practical realities of clinical workflows and procurement constraints to secure sustained adoption and improve patient care pathways.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Integration of robotic-assisted navigation in biopsy forceps systems to enhance precision during endoscopic diagnostics
• 5.2. Development of advanced biocompatible and shape-memory alloys for flexible biopsy forceps shafts to improve maneuverability in tortuous anatomy
• 5.3. Growing preference for disposable biopsy forceps among outpatient clinics driven by stringent infection control protocols
• 5.4. Emergence of cryobiopsy forceps technology gaining traction for larger and intact tissue samples in pulmonary diagnostics
• 5.5. Focus on ergonomic handle designs and tactile feedback enhancements to reduce physician fatigue during prolonged endoscopic procedures
• 5.6. Expansion of Asia Pacific biopsy forceps market fueled by rising cancer prevalence and increased endoscopic screening programs
• 5.7. Regulatory shifts tightening reprocessing standards for reusable biopsy forceps to minimize cross infection risks and ensure patient safety

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biopsy Forceps Market, by Product Type

• 8.1. Reusable
  • 8.1.1. Autoclavable
  • 8.1.2. Chemical Sterilization
• 8.2. Single Use
  • 8.2.1. Non Sterile
  • 8.2.2. Sterile

9. Biopsy Forceps Market, by Application

• 9.1. Bronchoscopy
  • 9.1.1. Conventional
  • 9.1.2. Endobronchial Ultrasound
• 9.2. Gastrointestinal Endoscopy
  • 9.2.1. Colonoscopy
  • 9.2.2. Esophagogastroduodenoscopy
• 9.3. Gynecology
• 9.4. Urology

10. Biopsy Forceps Market, by End User

• 10.1. Ambulatory Surgical Centers
• 10.2. Clinics
• 10.3. Hospitals

11. Biopsy Forceps Market, by Distribution Channel

• 11.1. Distributors
• 11.2. Hospital Procurement
• 11.3. Online Retail

12. Biopsy Forceps Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Biopsy Forceps Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Biopsy Forceps Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. Olympus Corporation
  • 15.3.2. Boston Scientific Corporation
  • 15.3.3. Medtronic plc
  • 15.3.4. Cook Medical LLC
  • 15.3.5. KARL STORZ SE & Co. KG
  • 15.3.6. HOYA Corporation
  • 15.3.7. Fujifilm Holdings Corporation
  • 15.3.8. CONMED Corporation
  • 15.3.9. STERIS plc
  • 15.3.10. Ambu A/S

LIST OF FIGURES

• FIGURE 1. GLOBAL BIOPSY FORCEPS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 11. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. EUROPE BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AFRICA BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASEAN BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GCC BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. BRICS BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. G7 BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. NATO BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. BIOPSY FORCEPS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 28. BIOPSY FORCEPS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. BIOPSY FORCEPS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL BIOPSY FORCEPS MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL BIOPSY FORCEPS MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY AUTOCLAVABLE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY AUTOCLAVABLE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY AUTOCLAVABLE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY AUTOCLAVABLE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY AUTOCLAVABLE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY AUTOCLAVABLE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CHEMICAL STERILIZATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CHEMICAL STERILIZATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CHEMICAL STERILIZATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CHEMICAL STERILIZATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CHEMICAL STERILIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CHEMICAL STERILIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY NON STERILE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY NON STERILE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY NON STERILE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY NON STERILE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY NON STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY NON STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY STERILE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY STERILE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY STERILE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY STERILE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CONVENTIONAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ENDOBRONCHIAL ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ENDOBRONCHIAL ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ENDOBRONCHIAL ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ENDOBRONCHIAL ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ENDOBRONCHIAL ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ENDOBRONCHIAL ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY COLONOSCOPY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY COLONOSCOPY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY COLONOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY COLONOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY COLONOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY COLONOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ESOPHAGOGASTRODUODENOSCOPY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ESOPHAGOGASTRODUODENOSCOPY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ESOPHAGOGASTRODUODENOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ESOPHAGOGASTRODUODENOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ESOPHAGOGASTRODUODENOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ESOPHAGOGASTRODUODENOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GYNECOLOGY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY UROLOGY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY UROLOGY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY UROLOGY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY UROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY HOSPITAL PROCUREMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY HOSPITAL PROCUREMENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY HOSPITAL PROCUREMENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY HOSPITAL PROCUREMENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY HOSPITAL PROCUREMENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY HOSPITAL PROCUREMENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 143. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 144. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 145. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 146. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 147. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
• TABLE 148. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
• TABLE 149. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
• TABLE 150. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2025-2032 (USD MILLION)
• TABLE 151. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 152. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 153. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2024 (USD MILLION)
• TABLE 154. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2025-2032 (USD MILLION)
• TABLE 155. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
• TABLE 156. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
• TABLE 157. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 158. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 159. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 160. AMERICAS BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 161. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 162. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 163. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 164. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 165. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
• TABLE 166. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
• TABLE 167. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
• TABLE 168. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2025-2032 (USD MILLION)
• TABLE 169. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 170. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 171. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2024 (USD MILLION)
• TABLE 172. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2025-2032 (USD MILLION)
• TABLE 173. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
• TABLE 174. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
• TABLE 175. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 176. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 177. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 178. NORTH AMERICA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 179. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 180. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 181. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 182. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 183. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
• TABLE 184. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
• TABLE 185. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
• TABLE 186. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2025-2032 (USD MILLION)
• TABLE 187. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 188. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 189. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2024 (USD MILLION)
• TABLE 190. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2025-2032 (USD MILLION)
• TABLE 191. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
• TABLE 192. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
• TABLE 193. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 194. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 195. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 196. LATIN AMERICA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 197. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 198. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 199. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 200. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 201. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
• TABLE 202. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
• TABLE 203. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
• TABLE 204. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2025-2032 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2024 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2025-2032 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
• TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 213. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 214. EUROPE, MIDDLE EAST & AFRICA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 215. EUROPE BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 216. EUROPE BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 217. EUROPE BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 218. EUROPE BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 219. EUROPE BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
• TABLE 220. EUROPE BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
• TABLE 221. EUROPE BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
• TABLE 222. EUROPE BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2025-2032 (USD MILLION)
• TABLE 223. EUROPE BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 224. EUROPE BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 225. EUROPE BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2024 (USD MILLION)
• TABLE 226. EUROPE BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2025-2032 (USD MILLION)
• TABLE 227. EUROPE BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
• TABLE 228. EUROPE BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
• TABLE 229. EUROPE BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 230. EUROPE BIOPSY FORCEPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 231. EUROPE BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 232. EUROPE BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 233. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 234. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 235. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 236. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 237. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
• TABLE 238. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
• TABLE 239. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
• TABLE 240. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2025-2032 (USD MILLION)
• TABLE 241. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 242. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 243. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2024 (USD MILLION)
• TABLE 244. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2025-2032 (USD MILLION)
• TABLE 245. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
• TABLE 246. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
• TABLE 247. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 248. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 249. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 250. MIDDLE EAST BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 251. AFRICA BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 252. AFRICA BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 253. AFRICA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 254. AFRICA BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 255. AFRICA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
• TABLE 256. AFRICA BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
• TABLE 257. AFRICA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
• TABLE 258. AFRICA BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2025-2032 (USD MILLION)
• TABLE 259. AFRICA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 260. AFRICA BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 261. AFRICA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2024 (USD MILLION)
• TABLE 262. AFRICA BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2025-2032 (USD MILLION)
• TABLE 263. AFRICA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
• TABLE 264. AFRICA BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
• TABLE 265. AFRICA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 266. AFRICA BIOPSY FORCEPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 267. AFRICA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 268. AFRICA BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 269. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 270. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 271. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 272. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 273. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
• TABLE 274. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
• TABLE 275. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
• TABLE 276. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2025-2032 (USD MILLION)
• TABLE 277. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 278. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 279. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2024 (USD MILLION)
• TABLE 280. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2025-2032 (USD MILLION)
• TABLE 281. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
• TABLE 282. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
• TABLE 283. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 284. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 285. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 286. ASIA-PACIFIC BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 287. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 288. GLOBAL BIOPSY FORCEPS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 289. ASEAN BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 290. ASEAN BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 291. ASEAN BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 292. ASEAN BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 293. ASEAN BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
• TABLE 294. ASEAN BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
• TABLE 295. ASEAN BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
• TABLE 296. ASEAN BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2025-2032 (USD MILLION)
• TABLE 297. ASEAN BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 298. ASEAN BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 299. ASEAN BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2024 (USD MILLION)
• TABLE 300. ASEAN BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2025-2032 (USD MILLION)
• TABLE 301. ASEAN BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
• TABLE 302. ASEAN BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
• TABLE 303. ASEAN BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 304. ASEAN BIOPSY FORCEPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 305. ASEAN BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 306. ASEAN BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 307. GCC BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 308. GCC BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 309. GCC BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 310. GCC BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 311. GCC BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
• TABLE 312. GCC BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
• TABLE 313. GCC BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
• TABLE 314. GCC BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2025-2032 (USD MILLION)
• TABLE 315. GCC BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 316. GCC BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 317. GCC BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2024 (USD MILLION)
• TABLE 318. GCC BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2025-2032 (USD MILLION)
• TABLE 319. GCC BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
• TABLE 320. GCC BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
• TABLE 321. GCC BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 322. GCC BIOPSY FORCEPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 323. GCC BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 324. GCC BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 325. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 326. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 327. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 328. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 329. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
• TABLE 330. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
• TABLE 331. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2018-2024 (USD MILLION)
• TABLE 332. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY SINGLE USE, 2025-2032 (USD MILLION)
• TABLE 333. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 334. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 335. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2018-2024 (USD MILLION)
• TABLE 336. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY BRONCHOSCOPY, 2025-2032 (USD MILLION)
• TABLE 337. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2024 (USD MILLION)
• TABLE 338. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2025-2032 (USD MILLION)
• TABLE 339. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 340. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 341. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 342. EUROPEAN UNION BIOPSY FORCEPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 343. BRICS BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 344. BRICS BIOPSY FORCEPS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 345. BRICS BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 346. BRICS BIOPSY FORCEPS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 347. BRICS BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
• TABLE 348. BRICS BIOPSY FORCEPS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
• TABLE 349. BRICS BIOPSY FORCE